マイクロRNA-374b-5pは,PDPK1媒介のAKT経路経由で,骨肉腫の進行を抑制する
Yong Xi1,2, Zhengyi Sun1, Jingbin Wu1
1Department of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, China.
Translational cancer research
|February 12, 2026
まとめ
マイクロRNA-374b-5p (miR-374b-5p) は,骨肉腫 (OS) で下調調節されている. 上位調節されたmiR-374b-5pは,PDPK1を標的とし,AKT経路を抑制することによって,OSの進行を阻害する.
科学分野:
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
- 遺伝子規制 遺伝子規制
背景:
- マイクロRNA (miRNA) は遺伝子発現を調節し,様々な生物学的プロセスに関与しています.
- 以前の研究は,いくつかのがんにおいて,マイクロRNA-374b-5p (miR-374b-5p) の抗腫瘍作用の可能性を示唆している.
- オステオサルコマ (OS) は,複雑な分子基盤を持つ主要な骨の悪性腫瘍です.
研究 の 目的:
- オステオサルコマ (OS) の進行におけるmiR-374b-5pの機能的役割を調査する.
- miR-374b-5pがOS発達に影響を与える基礎となる分子メカニズムを解明する.
- オステオサルコマにおけるmiR-374b-5pを標的とした治療の可能性を評価する.
主な方法:
- GSE65071データセット (GEOデータベース) の生物情報分析により,異なった発現のmiRNAsを特定する.
- qRT-PCRとFISHを用いたOS組織と細胞系におけるmiR-374b-5p発現の検証.
- CCK-8,コロニー形成,トランスウェル,フローサイトメトリーを含むインビトロアッセイで,OS細胞の増殖,移住,侵入,アポトーシスを評価する.
- qRT-PCR,二重ルシフェラゼレポーター分析,およびウェスタン・ブロッティングを含むメカニズム研究.
- 裸のマウスの異種移植腫瘍モデルを用いた体内評価.
主要な成果:
- miR-374b-5pの発現は,骨肉肉腫 (OS) 組織および細胞系において著しくダウンレギュレーションされた.
- miR-374b-5pの過剰発現は,OS細胞の増殖,移動,侵入を抑制し,同時にアポトーシスを促進しました.
- 仕組みの研究では,miR-374b-5pが直接フォスホイノシチド依存タンパク質キナーゼ1 (PDPK1) を標的にし,AKTシグナル伝達経路を抑制することを明らかにした.
- PDPK1はOSで高度に発現し,その静止はOSの進行を阻害しました.
- PDPK1の過剰発現は,OSの進行に対するmiR-374b-5pの抑制効果を,in vitroとin vivoの両方で部分的に逆転させた.
結論:
- miR-374b-5pは,骨髄腫 (OS) の腫瘍抑制剤として作用する.
- miR-374b-5pのアップレギュレーションは,PDPK1を直接標的とし,AKT経路を調節することにより,OSの進行を阻害する.
- miR-374b-5pは,オステオサルコマ治療の潜在的な治療標的を代表しています.
キーワード:
AKT AKT AKT AKT AKT AKT AKT AKT AKT AKT AKT AKT AKT AKT AKTmiR-374b-5pは,ミール-374b-5pは,ミール-374b-5pは,ミール-374b-5pは,ミール-374b-5pは,ミール-374b-5pはオステオサルコマ (OS) とはフォスホイノシチド依存タンパク質キナーゼ1 (PDPK1)さらに関連する動画
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.7K
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11.5K
関連する概念動画
PI3K/mTOR/AKT Signaling Pathway
5.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.7K
MicroRNAs
24.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs
4.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
C4 Pathway and CAM
49.3K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
C4 Pathway
The C4 pathway is used by plants such as...
49.3K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Nonsense-mediated mRNA Decay
11.9K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.9K
